The differences between the end point and the baseline showed that, the increases in BMI, ALT, AST, CHOL, TG, LDL-c, FBG and UA were higher (P < 0.001) in the newly onset NAFLD group than in patients who did not develop NAFLD (Table 1). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.